NCT02642809 2026-03-18
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Washington University School of Medicine
Phase 1 Completed
Clinical Trials
122 trialsNCT03315351 2026-03-13
TEP-Curie
Centre Oscar Lambret
Phase NA Completed
NCT07468903 2026-03-13
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT00525720 2026-03-09
Brachytherapy for Prostatic Carcinoma Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07182279 2026-03-09
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
The Methodist Hospital Research Institute
Phase 1/2 Recruiting
NCT04473781 2026-03-02
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT01946529 2026-02-23
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT02899221 2026-02-20
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Thomas Jefferson University
Phase NA Completed
NCT05320406 2026-02-12
REVELUTION
Emory University
Phase 2 Active not recruiting
NCT03543189 2026-01-29
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Active not recruiting
NCT03955978 2026-01-06
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Washington University School of Medicine
Phase 1 Active not recruiting
NCT01871766 2025-12-17
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT03422198 2025-12-12
SAVE
University of Utah
Phase 3 Recruiting
NCT07276360 2025-12-11
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Not yet recruiting
NCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT05754580 2025-11-05
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
University of Nebraska
Phase NA Recruiting
NCT05100472 2025-11-04
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03634267 2025-10-14
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02467738 2025-09-19
Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04253483 2025-09-17
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
Rutgers, The State University of New Jersey
Phase 2 Active not recruiting
NCT05893654 2025-09-15
MELCOM
Hospital das ClÃnicas de Ribeirão Preto
Phase 1/2 Enrolling by invitation
NCT01655836 2025-09-11
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Thomas Jefferson University
Phase 1 Active not recruiting
NCT07152678 2025-09-03
BRIGHT-ESCC
National Taiwan University Hospital
Phase 2 Recruiting
NCT01777802 2025-08-27
SBRT
Mayo Clinic
Completed
NCT07132073 2025-08-27
MRI-guided Locoregional SBRT Prostate Program
Clinica Universidad de Navarra, Universidad de Navarra
Phase NA Not yet recruiting
NCT07132671 2025-08-20
MRI-guided Brachytherapy and Salvage SBRT Program
Clinica Universidad de Navarra, Universidad de Navarra
Phase NA Not yet recruiting
NCT06023641 2025-08-19
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
St. Jude Children's Research Hospital
Phase 2 Recruiting
NCT07121543 2025-08-13
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
University of California, San Diego
Recruiting
NCT04945642 2025-07-15
HYDRA
Jonsson Comprehensive Cancer Center
Phase NA Recruiting
NCT06982469 2025-06-19
High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Clinica Universidad de Navarra, Universidad de Navarra
Recruiting
NCT05715502 2025-04-30
FocaSaBra
The Greater Poland Cancer Centre
Phase NA Recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT02346253 2025-04-03
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stanford University
Phase NA Active not recruiting
NCT04049747 2025-03-24
IP4-CHRONOS
Imperial College London
Phase NA Completed
NCT00185744 2025-03-20
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
Stanford University
Phase NA Active not recruiting
NCT00769223 2025-03-20
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
University of California, San Francisco
Active not recruiting
NCT06882473 2025-03-18
A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
Peking University Third Hospital
Phase NA Not yet recruiting
NCT06872606 2025-03-12
SCRIPBOT
Sir Run Run Shaw Hospital
Phase 2 Not yet recruiting
NCT05224869 2025-02-26
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
Icahn School of Medicine at Mount Sinai
Phase NA Terminated
NCT05663294 2025-02-03
PRISCILLA
Istituto Clinico Humanitas
Phase NA Active not recruiting
NCT06752135 2024-12-30
HRCC1
Azienda Policlinico Umberto I
Terminated
NCT03277469 2024-10-31
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT06288373 2024-10-30
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Tongji Hospital
Phase 2/3 Recruiting
NCT06524778 2024-08-07
Single High-dose Brachytherapy for Giant Osteosarcoma Masses
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 2 Not yet recruiting
NCT03753659 2024-07-22
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT06419673 2024-05-17
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT01783535 2024-04-16
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT06350825 2024-04-05
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Recruiting
NCT05057195 2024-04-01
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy
Blokhin's Russian Cancer Research Center
Phase NA Recruiting
NCT02280356 2024-03-04
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed